NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: NeuroOne's Upcoming Industry Conference Participation
TL;DR
NeuroOne's participation in key medical conferences provides investors early access to emerging neurological treatment innovations and potential market advantages.
NeuroOne will present at the AES Annual Meeting focusing on epilepsy outcomes and the CNS Drug Delivery Summit addressing brain access challenges.
NeuroOne's conference participation advances neurological disorder treatments potentially improving patient care and surgical outcomes for epilepsy and Parkinson's disease.
NeuroOne joins leading neuroscience conferences exploring cutting-edge brain technologies from EEG recording to drug delivery for neurological conditions.
Found this article helpful?
Share it with your network and spread the knowledge!
NeuroOne Medical Technologies Corporation announced its participation in two upcoming medical industry conferences: the American Epilepsy Society 2025 Annual Meeting and the CNS Drug Delivery Summit.
NeuroOne will participate in the American Epilepsy Society 2025 Annual Meeting from December 5-9, 2025 in Atlanta, GA, and the CNS Drug Delivery Summit from December 9-11, 2025 in Boston, MA.
NeuroOne focuses on developing and commercializing minimally invasive and hi-definition solutions for EEG recording, monitoring, ablation, drug delivery and stimulation solutions for patients suffering from neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors.
These conferences bring together healthcare providers, scientists, industry professionals, and experts dedicated to improving outcomes for neurological disorders, providing NeuroOne opportunities to collaborate, network, and share cutting-edge strategies in their field.
The CNS Drug Delivery Summit attracts 100+ industry experts including neuroscientists, chemists, device engineers, conjugation scientists, DMPK experts, and delivery specialists focused on tackling challenges in brain access and drug delivery.
For more information about NeuroOne, visit their website at nmtc1.com or contact their investor relations at NMTC@mzgroup.us.
NeuroOne's solutions target epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders, with potential future applications for depression, mood disorders, pain, and other conditions.
Registration information for the AES Annual Meeting can be found on their website at AES Annual Meeting Registration.
For investor relations inquiries, contact MZ Group – MZ North America at NMTC@mzgroup.us.
Curated from NewMediaWire
